CP-SCD Announces Pfizer Executive as its First Industry Co-Director C-Path’s Critical Path to Sickle Cell Disease Consortium (CP-SCD) is pleased to announce Dr. David Readett of Pfizer as its firs
May 7, 2021 COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials Virtual Workshop COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials Virtual Workshop Friday May 7, 2021 12:00 – 1:30 pm Ea
April 7, 2021 FAIR data sharing: The roles of common data elements and harmonization. Journal of Biomedical Informatics. 2020 July D. Kush, D. Warzel, M.A. Kush, A. Sherman, E.A. Navarro, R. Fitzmartin, F. Pétavy, J. Galvez, L.B. Becnel, F.L. Zhou, N. Harmon..
April 7, 2021 Standardized Data Structures in Rare Diseases: CDISC User Guides for Duchenne Muscular Dystrophy and Huntington’s Disease Mullin, A.P., Corey, D., Turner, E.C., Liwski, R., Olson, D., Burton, J., Sivakumaran, S., Hudson, L.D., Romero, K., Stephenson, D
April 7, 2021 Development of a regulatory-ready clinical trial simulation tool for Duchenne muscular dystrophy Abstract WMS 2020
April 7, 2021 Development of a regulatory-ready clinical trial simulation tool for Duchenne muscular dystrophy poster WMS 2020
April 7, 2021 Development of Clinical Trial Simulation Tool for Duchenne Muscular Dystrophy Through the Duchenne Regulatory Science Abstract WMS 2019
April 7, 2021 Development of Clinical Trial Simulation Tool for Duchenne Muscular Dystrophy Through the Duchenne Regulatory Science Poster WMS 2019
C-Path Welcomes Dr. Ramona Belfiore Oshan as D-RSC Associate Director C-Path is pleased to welcome Ramona Belfiore Oshan, Ph.D., as the new Associate Director for its Duchenne Regulatory Science
Cures Within Reach Names CURE ID as 2021 Patient Impact Awardee Cures Within Reach, a global nonprofit leading the use of repurposing research to help improve patients’ lives, has a